Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 28Recruiting 11Active not recruiting 7Unknown 4Terminated 4Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 989Neoplasms 848Carcinoma, Non-Small-Cell Lung 842Prostatic Neoplasms 527Neoplasm Metastasis 500Leukemia, Myeloid, Acute 488Melanoma 453Colorectal Neoplasms 446Multiple Myeloma 440Lung Neoplasms 419Pancreatic Neoplasms 352Recurrence 350Lymphoma 349Ovarian Neoplasms 341Lymphoma, Non-Hodgkin 327Leukemia 323Leukemia, Lymphocytic, Chronic, B-Cell 301Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Carcinoma, Renal Cell 256Head and Neck Neoplasms 246Brain Neoplasms 243Carcinoma, Hepatocellular 234Squamous Cell Carcinoma of Head and Neck 231Glioblastoma 231Myelodysplastic Syndromes 229Lymphoma, Large B-Cell, Diffuse 228Lymphoma, Follicular 219Colonic Neoplasms 191Stomach Neoplasms 182Rectal Neoplasms 175

Interventions

Vinblastine 1Paclitaxel 1Imatinib Mesylate 1Ifosfamide 1Cisplatin 1Carboplatin 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Interventional × Seminoma × Clear all
NCT01593241 2025-02-13

Therapy De-escalation in Seminoma Stage IIA/B

Swiss Cancer Institute

Phase 2 Terminated
120 enrolled

Seminoma

NCT01055067 2021-04-06

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Daiichi Sankyo

Phase 2 Terminated
27 enrolled 6 charts

Seminoma

NCT00072215 2016-07-04

Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors

Alliance for Clinical Trials in Oncology

Phase 3 Terminated
1 enrolled
Genitourinary

Testicular Germ Cell Tumor, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

NCT00042952 2013-01-17

Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
32 enrolled
Genitourinary

Dysgerminoma, Testicular Neoplasms, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡